| 000 | 01339 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516011920.0 | ||
| 264 | 0 | _c20110607 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1549-490X | ||
| 024 | 7 |
_a10.1634/theoncologist.2010-0162 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSepe, Dana M | |
| 245 | 0 | 0 |
_aDexrazoxane as a cardioprotectant in children receiving anthracyclines. _h[electronic resource] |
| 260 |
_bThe oncologist _c2010 |
||
| 300 |
_a1220-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAnthracyclines _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArrhythmias, Cardiac _xchemically induced |
| 650 | 0 | 4 |
_aCardiomyopathies _xchemically induced |
| 650 | 0 | 4 |
_aCardiotonic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aHeart Failure _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRazoxane _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGinsberg, Jill P | |
| 700 | 1 | _aBalis, Frank M | |
| 773 | 0 |
_tThe oncologist _gvol. 15 _gno. 11 _gp. 1220-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1634/theoncologist.2010-0162 _zAvailable from publisher's website |
| 999 |
_c20350654 _d20350654 |
||